Brandi Howard, APRN
Nurse Practitioner · Spartanburg, SCNPI 1265009591
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 323 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $3,397 and has fallen 85.8% since, to $482 in 2025. Among nurse practitioner clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 323 payments — averaging $21.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- GSK$1K
- Boehringer Ingelheim$770
- Regeneron Healthcare Solutions, Inc.$510
- Sanofi$480
- Actelion Pharmaceuticals US, Inc.$477
- plus $3K from 29 others
What the payments were for
- Food & beverage$6,94998%
- Education$1062%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 34 | $1,261 |
| GSK | 63 | $1,046 |
| Boehringer Ingelheim | 34 | $770 |
| Regeneron Healthcare Solutions, Inc. | 22 | $510 |
| Sanofi | 18 | $480 |
| Actelion Pharmaceuticals US, Inc. | 13 | $477 |
| Electromed, Inc. | 24 | $309 |
| Mallinckrodt Hospital Products Inc. | 12 | $305 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $284 |
| United Therapeutics Corporation | 12 | $247 |
| Amgen | 20 | $239 |
| AbbVie | 3 | $126 |
| Novartis | 7 | $119 |
| Bayer | 5 | $106 |
| Mylan Specialty L.p. | 6 | $89 |
| Sanofi-aventis U.S. LLC | 1 | $77 |
| ANI Pharmaceuticals, Inc. | 5 | $72 |
| Philips North America LLC | 4 | $69 |
| Novo Nordisk | 4 | $59 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| Pfizer | 3 | $45 |
| Insmed, Inc. | 2 | $40 |
| Hikma Pharmaceuticals USA | 2 | $33 |
| Resmed Corp | 2 | $29 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $24 |
| Shionogi Inc | 1 | $23 |
| Inogen, Inc. | 1 | $22 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $22 |
| Baxter Healthcare | 1 | $21 |
| Johnson & Johnson | 2 | $20 |
| Grifols USA, LLC | 1 | $18 |
| Merck | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Dexcom, Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,055 in reported general payments places this provider in the 95th percentile of 1,346 nurse practitioner providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 583 | $455,325 |
| Dupixent PenDupilumab | 40 | $170,981 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 123 | $88,955 |
| GlassiaAlpha-1-Proteinase Inhibitor | 46 | $87,684 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 137 | $74,487 |
| Spiriva RespimatTiotropium Bromide | 78 | $48,592 |
| Breo ElliptaFluticasone/Vilanterol | 68 | $35,065 |
| SymbicortBudesonide/Formoterol Fumarate | 104 | $33,834 |
| Pirfenidone | 16 | $29,381 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 48 | $28,979 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 54 | $27,963 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 514 | $15,681 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 75 | $11,679 |
| Incruse ElliptaUmeclidinium Bromide | 26 | $11,289 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 14 | $8,288 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta | $1,046 | $576,166814 claims |
| AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere | $1,261 | $131,077241 claims |
| Boehringer IngelheimSpiriva Respimat, Stiolto Respimat, Combivent Respimat | $770 | $105,534180 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Glassia | $284 | $87,68446 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,346 nurse practitioner providers in South Carolina.
Other nurse practitioner in Spartanburg
- Kimberly ValentiSpartanburg$14K
- Elizabeth EveretteSpartanburg$12K
- Supinder ChannaSpartanburg$11K
- Samantha BlackwellSpartanburg$10K
- Catherine VoelkerSpartanburg$8K
- Brandy MurraySpartanburg$8K
- David WiltGreenville$90K
- Whitney ReedCharleston$54K
- Mary JohnsonCharleston$34K
- Amanda HareCharleston$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.